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aRecent studies have increased interest in quantify-
ing absolute myocardial blood flow (MBF) nonin-
vasively, particularly in maximally vasodilated cor-
onary vascular beds. Reductions unrelated to
epicardial coronary artery disease have become an
important tool in the identification of microvascular
dysfunction. Sequential measurements have pro-
vided useful insights into microvascular pathophys-
iology and treatment. Novel therapies designed to
stimulate angiogenesis and myocardial regeneration
may exert their effect via improvement in microvas-
cular flow.
See page 990
In contrast to values of coronary flow reserve
(CFR), values of vasodilated absolute MBF are
unaffected by levels of “resting” flow. They do,
however, vary directly with changes in arterial
pressure and inversely with changes in heart rate
(1). In healthy normal individuals, vasodilation can
increase resting absolute MBF 4- to 5-fold, reach-
ing levels of 4 ml/g/min with only modest
changes in heart rate and arterial pressure. Thus,
maximum vasodilation uncouples the usual close
relationship between myocardial oxygen demand
and coronary flow, and usually increases absolute
MBF above the level needed for fairly vigorous
physical activity.
Positron emission tomography (PET) has tradi-
tionally been the noninvasive standard for quanti-
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to the contents of this paper to disclose.ying absolute MBF (2). Magnetic resonance, com-
uted tomographic, and echocardiographic
pproaches are now being used in some laborato-
ies. Absolute MBF can also be measured using
ynamic single-photon emission computed tomog-
aphy (3), but cameras with sufficient speed and
ount sensitivity are not yet widely available.
bsolute MBF and perfusion scans in coronary artery
isease. Routine myocardial perfusion scans iden-
ify only relative differences in regional tracer activ-
ty and assume the presence of at least 1 normally
erfused area to which others can be compared.
easurements of absolute MBF can aid in inter-
retation in patients with coronary artery disease,
or example, when a normal or near-normal stress
can may reflect an unappreciated global reduction
n flow in a patient with diffuse triple vessel disease.
f hemodynamically important lesions are indeed
idespread, vasodilated absolute MBF should be
educed globally.
Regional perfusion defects developing during
harmacological vasodilation present more frequent
nterpretive issues. Because myocardial oxygen de-
and increases only modestly, ischemia is infre-
uent. In the absence of ischemia, measurements of
asodilated absolute MBF add information con-
erning residual flow reserve, including limitations
elated to microvascular dysfunction as well as
iffering degrees of epicardial stenosis. Hajjiri et al.
4) have reported that 13N-ammonia measurements
f adenosine-stimulated absolute MBF are superior
o quantitative measurements of relative tracer re-
ention in identifying coronary artery disease, and
hat a single measurement of vasodilated absolute
BF is adequate for this purpose. The possibility
hat the magnitude of reduction in vasodilated
bsolute MBF can provide useful information about
isease severity merits exploration.
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1000PETmeasurements of absoluteMBFduringdipyridamole-
induced vasodilation. In this issue of iJACC, John-
son and Gould (5) review their laboratory’s experi-
ence in quantifying absolute MBF with PET in an
attempt to define low-flow threshold values of
absolute MBF and CFR that are associated with
regional ischemia during dipyridamole-induced va-
sodilation. A total of 1,674 perfusion scans and
absolute MBF measurements were performed in
1,370 patients, primarily using 82Rb. Responses
ere classified into 3 categories:
. “Definite” ischemia: studies showing a new or
worsened scan defect during vasodilation ac-
companied by either 1-mm ST-segment de-
pression or angina requiring pharmacological
treatment.
. “Indeterminate” responders: studies showing at
least 1 of these abnormalities during vasodila-
tion. The large majority (71%) represented new
or worsened scan defects not accompanied by
ST-segment depression or angina.
. “No” ischemia: studies showing none of the
aforementioned abnormalities and no scinti-
graphic evidence of myocardial scar.
nlike studies using region-of-interest analysis,
bsolute MBF values were computed on a per-pixel
asis (see text of reference [5] for details). Results
or “worst” flow and CFR referred to individual
ixels and were, therefore, less than average values
or an entire perfusion defect or reference area.
dditionally, the anatomical location of a “worst”
ixel could differ between rest and vasodilator
tress.
Definite ischemia was identified in only 12% of
tudies; 18% fell into the indeterminate group, 20%
howed myocardial scar, and the remaining 50%
onstituted the no ischemia group. Worst vasodi-
ated absolute MBF averaged 0.47  0.26 ml/g/
in, 0.81  0.47 ml/g/min, and 1.56  0.54
ml/g/min in the definite, indeterminate, and no
ischemia categories.
The definite and no ischemia groups were sharply
separated at a vasodilated worst absolute MBF
cutoff of 0.91 ml/g/min, with an area under the
corresponding receiver-operator characteristic curve
of 0.98. Flows in indeterminate cases showed
greater overlap with the no ischemia group, al-
though the receiver-operator characteristic curve for
a worst absolute MBF cutoff of 1.12 ml/g/min still
had an area under the curve of 0.86.
Separation between cases of definite ischemia
and indeterminate responders was less clear: 66%(198/301) of worst stress flows in indeterminate
responders fell below the 0.91 ml/g/min cutoff for
definite versus no ischemia. The worst flow cutoff
for optimal separation between definite and inde-
terminate groups (0.52 ml/g/min) did not differ
appreciably from the average worst flow in cases of
definite ischemia (0.47 ml/g/min).
Although this study provides information about
worst per-pixel absolute MBF in an unusually large
number of patients, the authors caution that the
data “will require further extended study before
understanding their clinical relevance.” When a
vasodilation-induced perfusion defect is accompa-
nied by ST-segment depression or clear-cut angina,
a worst absolute MBF 0.91 ml/g/min can be
expected in 90% of cases. ST-segment depression
and/or angina are infrequent when worst vasodi-
lated absolute MBF exceeds 1.12 ml/g/min. How-
ever, the specificity and positive predictive accuracy
of absolute MBF for identifying vasodilation-
induced scan defects that do produce ischemia are
affected adversely by the overlap of worst per-pixel
values in definite and indeterminate cases. As the
authors discuss, decisions concerning further diag-
nostic evaluation depend on the size of the perfu-
sion defect as well as the severity of reduction in
absolute MBF and other clinical factors.
The present findings were likely influenced, al-
beit to an unknown degree, by drug treatment at the
time of study. As noted previously, values of abso-
lute MBF during maximum vasodilation are influ-
enced by absolute levels of heart rate and blood
pressure, both of which can be altered by agents
such as beta blockers, calcium blockers, and nitrates.
Similarly, statins and other agents may affect
endothelial-dependent components of maximum
vasodilation.
As the authors also point out, cardiac PET
quantifies average transmural flow and is ordinarily
unable to distinguish subendocardial from subepi-
cardial perfusion. Subendocardial flow is normally
less than subepicardial flow during maximum vaso-
dilation, and the magnitude of the difference can
increase during ischemia (1). Thus, the separation
between cases of definite ischemia and those with
indeterminate clinical features would likely be en-
hanced if subendocardial absolute MBF could be
quantified selectively. Because of its superior reso-
lution, magnetic resonance imaging is being inves-
tigated actively in this regard. Limitations requiring
continuing attention include subendocardial arti-
facts, less-than-complete ventricular coverage, and
a nonlinear relationship between signal intensity
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1001and gadolinium tracer concentration that assumes
greater importance as flow increases (6).
Methodological standardization. Noninvasive mea-
urements of absolute MBF in individual laborato-
ies can be expected to contribute usefully in con-
inuing studies of coronary pathophysiology and
elected clinical issues. As Gewirtz (7) has empha-
ized, however, multi-institutional PET studies re-
ain limited by differences in tracers, kinetic mod-
ls, technical methodology, image analysis, and
harmacological vasodilating agents. For example,
eported PET stress flows in normal individualsitors. Clinical Nuclear Cardiology:
4
5
6
of absolute myocardith a 27% weighted average coefficient of variation
or single measurements (Table 4 in reference [8]).
imilar multi-institutional information for other
maging modalities is limited but equally important.
ptions for improving methodological standardiza-
ion deserve careful study and may prove an impor-
ant determinant of the ultimate clinical utility of
bsolute MBF measurements.
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